On-Demand Video Panel Discussion

Share

Program Content

Activities

  • MRD in ALL
    Measurable Residual Disease in ALL: Proof of the Principle Transforming Care for Patients With Hematologic Malignancies
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 01, 2018

    Expires: November 08, 2019

Provided by

ProCE Banner

Supporters

Adaptive Biotechnologies

Amgen, Inc.

Partners

GRACE

ProCE Banner